Amber Wolf‐Ringwall

Clinical validation of a next-generation sequencing-based multi-cancer early detection “liquid biopsy” blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study

Andi Flory, Kristina M. Kruglyak, John A. Tynan et al. · PLoS ONE · 2022 · 52 citations · Full text

The anti-diabetic bis(maltolato)oxovanadium(iv) decreases lipid order while increasing insulin receptor localization in membrane microdomains

Peter W. Winter, Abeer Al-Qatati, Amber Wolf‐Ringwall et al. · Dalton Transactions · 2012 · 51 citations

Prospective evaluation of flow cytometric characteristics, histopathologic diagnosis and clinical outcome in dogs with naïve B‐cell lymphoma treated with a 19‐week CHOP protocol

Amber Wolf‐Ringwall, Lynelle Lopez, Robyn Elmslie et al. · Veterinary and Comparative Oncology · 2019 · 41 citations

Immunology, Pathology, Canine B-cell Lymphoma +18

Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor

Charles Halsey, Daniel L. Gustafson, Barbara Rose et al. · BMC Veterinary Research · 2014 · 27 citations · Full text

Insulin Receptors and Downstream Substrates Associate with Membrane Microdomains after Treatment with Insulin or Chromium(III) Picolinate

Abeer Al-Qatati, Peter W. Winter, Amber Wolf‐Ringwall et al. · Cell Biochemistry and Biophysics · 2011 · 18 citations

Insulin Receptors, Proteinlipid Interaction, Downstream Substrates Associate +9